Collegium Pharmaceutical
COLL
COLL
179 hedge funds and large institutions have $816M invested in Collegium Pharmaceutical in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 54 increasing their positions, 69 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3.15% less ownership
Funds ownership: 110.69% → 107.55% (-3.1%)
22% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 69
Holders
179
Holding in Top 10
2
Calls
$2.09M
Puts
$32K
Top Buyers
| 1 | +$9.67M | |
| 2 | +$6.99M | |
| 3 | +$6.2M | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$5.75M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.89M |
Top Sellers
| 1 | -$54.5M | |
| 2 | -$9.95M | |
| 3 | -$2.45M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.14M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$2.12M |